These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11872874)

  • 1. Major improvements in cost effectiveness of screening women for Chlamydia trachomatis using pooled urine specimens and high performance testing.
    Morré SA; Welte R; Postma MJ
    Sex Transm Infect; 2002 Feb; 78(1):74-5. PubMed ID: 11872874
    [No Abstract]   [Full Text] [Related]  

  • 2. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Habets PC
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario.
    Goeree R; Jang D; Blackhouse G; Chong S; Mahony J; Sellors J; Foy A; Chernesky M
    Sex Transm Dis; 2001 Dec; 28(12):701-9. PubMed ID: 11725225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing cost effectiveness of screening women for Chlamydia trachomatis in systematic and opportunistic approaches.
    Postma MJ; Welte R; van den Hoek JA; Morré SA
    Sex Transm Infect; 2002 Feb; 78(1):73-4. PubMed ID: 11872873
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infection in women.
    Gupta M; Hernon M; Gokhale R; Ghosh AK
    Sex Transm Infect; 2002 Feb; 78(1):76. PubMed ID: 11872877
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home.
    Novak DP; Lindholm L; Jonsson M; Karlsson RB
    Scand J Public Health; 2004; 32(5):324-32. PubMed ID: 15513664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
    van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia trachomatis screening in the adolescent population.
    Holder DW; Woods ER
    Curr Opin Pediatr; 1997 Aug; 9(4):317-24. PubMed ID: 9300187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR; Gaydos CA; Quinn TC
    Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples.
    van Bergen JE; Postma MJ; Peerbooms PG; Spangenberg AC; Tjen-A-Tak J; Bindels PJ
    Int J STD AIDS; 2004 Dec; 15(12):797-802. PubMed ID: 15601485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
    Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health and cost-benefits of chlamydia screening in young women.
    Mangione-Smith R; O'Leary J; McGlynn EA
    Sex Transm Dis; 1999 Jul; 26(6):309-16. PubMed ID: 10417017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Towards screening for Chlamydia trachomatis].
    Kolmos HJ
    Ugeskr Laeger; 1997 Aug; 159(34):5104-5. PubMed ID: 9297316
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.
    Randolph AG; Washington AE
    Am J Public Health; 1990 May; 80(5):545-50. PubMed ID: 2109544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooling of urine specimens allows accurate and cost-effective genetic detection of Chlamydia trachomatis in Lithuania and other low-resource countries.
    Butylkina R; Juseviciute V; Kasparaviciene G; Vagoras A; Pagirskas E; Unemo M; Domeika M
    Scand J Infect Dis; 2007; 39(3):209-12. PubMed ID: 17366049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia trachomatis infection among women 26 to 39 years of age in the United States, 1999 to 2010.
    Torrone EA; Geisler WM; Gift TL; Weinstock HS
    Sex Transm Dis; 2013 Apr; 40(4):335-7. PubMed ID: 23486500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.